XML 31 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Estimates of Fair Values of Assets Acquired and Liabilities Assumed of Clinical Research Management, Inc. (Detail) - USD ($)
$ in Thousands
Sep. 15, 2016
Sep. 30, 2016
Dec. 31, 2015
 [1]
Dec. 31, 2014
Business Acquisition [Line Items]        
Goodwill   $ 626,657 $ 588,434 $ 463,324
Clinical Research Management Inc.        
Business Acquisition [Line Items]        
Cash $ 1,842      
Property, plant and equipment 938      
Goodwill [2] 39,376      
Intangible assets [3] 9,844      
Accounts receivable 11,815      
Unbilled revenue 4,160      
Prepayments and other current assets 2,012      
Accounts payable (917)      
Other liabilities (4,667)      
Non-current other liabilities (7)      
Net assets acquired 64,396      
Cash consideration 52,396      
Contingent consideration $ 12,000      
[1] The December 31, 2015 Balance Sheet has been retrospectively restated as required to reflect the requirements of new guidance in respect of the presentation of debt issue costs.
[2] Goodwill represents the acquisition of an established workforce with experience in preclinical through Phase IV support of clinical research and clinical trial services for biologics, drugs and devices.
[3] The Company has made an initial estimate of separate intangible assets acquired of $9.8 million. This assessment is under review and will be finalized within 12 months of the date of acquisition.